Cargando…

Atomoxetine-induced focal seizures with contralateral hypoperfusion and hyper-CKemia

One of the drugs used to treat attention deficit hyperactivity syndrome is atomoxetine. Usually, the drug is well tolerated but in rare cases adverse advents may occur. An 18-year-old female under atomoxetine (60 mg/d) since 2 years for attention deficit hyperactivity syndrome since age 13 years, de...

Descripción completa

Detalles Bibliográficos
Autores principales: Finsterer, Josef, Scorza, Fulvio A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206568/
https://www.ncbi.nlm.nih.gov/pubmed/34168713
http://dx.doi.org/10.1016/j.radcr.2020.11.049
_version_ 1783708655154102272
author Finsterer, Josef
Scorza, Fulvio A.
author_facet Finsterer, Josef
Scorza, Fulvio A.
author_sort Finsterer, Josef
collection PubMed
description One of the drugs used to treat attention deficit hyperactivity syndrome is atomoxetine. Usually, the drug is well tolerated but in rare cases adverse advents may occur. An 18-year-old female under atomoxetine (60 mg/d) since 2 years for attention deficit hyperactivity syndrome since age 13 years, developed sudden onset headache, hemianopia to the right, hypoesthesia of the tongue and right arm, aphasia, and depersonalisation. Blood tests revealed hyper-CK-emia of 2860U/L, cerebral magnetic resonance imaging showed disturbed perfusion on the left temporo-parieto-occipital region, and electroencephalography (EEG) revealed focal slowing and spikes and sharp waves in the same projections. After discontinuation of atomoxetine, symptoms, EEG, and magnetic resonance imaging findings resolved spontaneously within 48 hours. In conclusion, atomoxetine may rarely cause severe side effects such as complex partial seizures with CK-elevation, transient hypoperfusion of the temporal, parietal and occipital lobes, and prolonged reorientation. Atomoxetine should be discontinued if such side effects occur.
format Online
Article
Text
id pubmed-8206568
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82065682021-06-23 Atomoxetine-induced focal seizures with contralateral hypoperfusion and hyper-CKemia Finsterer, Josef Scorza, Fulvio A. Radiol Case Rep Case Report One of the drugs used to treat attention deficit hyperactivity syndrome is atomoxetine. Usually, the drug is well tolerated but in rare cases adverse advents may occur. An 18-year-old female under atomoxetine (60 mg/d) since 2 years for attention deficit hyperactivity syndrome since age 13 years, developed sudden onset headache, hemianopia to the right, hypoesthesia of the tongue and right arm, aphasia, and depersonalisation. Blood tests revealed hyper-CK-emia of 2860U/L, cerebral magnetic resonance imaging showed disturbed perfusion on the left temporo-parieto-occipital region, and electroencephalography (EEG) revealed focal slowing and spikes and sharp waves in the same projections. After discontinuation of atomoxetine, symptoms, EEG, and magnetic resonance imaging findings resolved spontaneously within 48 hours. In conclusion, atomoxetine may rarely cause severe side effects such as complex partial seizures with CK-elevation, transient hypoperfusion of the temporal, parietal and occipital lobes, and prolonged reorientation. Atomoxetine should be discontinued if such side effects occur. Elsevier 2020-12-06 /pmc/articles/PMC8206568/ /pubmed/34168713 http://dx.doi.org/10.1016/j.radcr.2020.11.049 Text en © 2020 The Authors. Published by Elsevier Inc. on behalf of University of Washington. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Finsterer, Josef
Scorza, Fulvio A.
Atomoxetine-induced focal seizures with contralateral hypoperfusion and hyper-CKemia
title Atomoxetine-induced focal seizures with contralateral hypoperfusion and hyper-CKemia
title_full Atomoxetine-induced focal seizures with contralateral hypoperfusion and hyper-CKemia
title_fullStr Atomoxetine-induced focal seizures with contralateral hypoperfusion and hyper-CKemia
title_full_unstemmed Atomoxetine-induced focal seizures with contralateral hypoperfusion and hyper-CKemia
title_short Atomoxetine-induced focal seizures with contralateral hypoperfusion and hyper-CKemia
title_sort atomoxetine-induced focal seizures with contralateral hypoperfusion and hyper-ckemia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206568/
https://www.ncbi.nlm.nih.gov/pubmed/34168713
http://dx.doi.org/10.1016/j.radcr.2020.11.049
work_keys_str_mv AT finstererjosef atomoxetineinducedfocalseizureswithcontralateralhypoperfusionandhyperckemia
AT scorzafulvioa atomoxetineinducedfocalseizureswithcontralateralhypoperfusionandhyperckemia